Downloads: 1 | Views: 167 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Research Paper | Obstetrics and Gynecology | India | Volume 13 Issue 1, January 2024 | Popularity: 5.2 / 10
A Comparative Study of Intravenous and Intramuscular Administration of Magnesium Sulfate in Eclampsia
Dr. Athulya Surendran, Dr. Jyotsna Deshmukh, Dr. Sonali Deshmukh
Abstract: Introduction: Hypertensive disorder of pregnancy (HDP) is a common pregnancy complication involving the activation and injury of maternal endothelial cells. The Pritchard regimen is the standard protocol for managing eclampsia, and magnesium sulfate is the most popular anticonvulsant. This study aimed to evaluate the efficacy and advantages of intravenously administered magnesium sulfate for control of convulsion and prevention of its recurrence in women with eclampsia. Methodology: The study aimed to compare the efficacy and safety of an intravenous (Zuspan) and intramuscular (Pritchard's) magnesium sulfate regimen for pregnant patients presenting with eclampsia. The study population consisted of 80 pregnant patients above 20 weeks presenting with eclampsia at a tertiary care center. The study used a single blind randomized comparative study, with a sample size of 40 subjects in each group. The patients were divided into two groups: Group A, given the standard Pritchard's regimen (intramuscular), and Group B, given the standard Zuspan regimen (intravenous). Results: The study analyzed 80 pregnant patients above 20 weeks presenting with eclampsia at a tertiary care center. The majority of cases were primigravida?s, with 63.8% being multigravidas. The majority of cases were primigravida?s, with 63.7% being preterm. The study found no statistical difference in the control of convulsions or the need for additional doses after receiving the standard dose of MgSo4. Conclusion: Both intramuscular and intravenous magnesium sulfate regimens were effective in preventing convulsions in eclampsia cases. However, intramuscular magnesium sulfate has a higher incidence of magnesium toxicity, leading to complications like respiratory depression.
Keywords: Eclampsia, Hypertensive disorder of pregnancy, Maternal mortality, Pregnancy complications, Pritchard, Zuspan
Edition: Volume 13 Issue 1, January 2024
Pages: 1777 - 1788
DOI: https://www.doi.org/10.21275/MR24122234201
Make Sure to Disable the Pop-Up Blocker of Web Browser
Similar Articles
Downloads: 0
Research Paper, Obstetrics and Gynecology, India, Volume 10 Issue 10, October 2021
Pages: 1076 - 1079Blood Transfusion Practices in Obstetrics PT in a Tertiary Hospital
Subhashini Trivedi, Dr. Archana Singh, Dr. Prakash Chandra Mishra
Downloads: 0
Research Paper, Obstetrics and Gynecology, India, Volume 11 Issue 11, November 2022
Pages: 197 - 200Acute Kidney Injury in Pregnancy and Puerperium- A Prospective Observational Study in a Tertiary Care Institute
Dr. R. Rajarajeswari, Dr. Uma Brindha .J, Dr. J. Vaishnavi
Downloads: 0
Research Paper, Obstetrics and Gynecology, India, Volume 11 Issue 12, December 2022
Pages: 636 - 641Role of Platelet Distribution Width and Mean Platelet Volume in Assessment of Severity of Pre Eclampsia - A Prospective Observational Study in Tertiary Care Centre
Dr. R. Rajarajeswari, Dr. Dr. B. Meenambiga, Dr. P. Manju Priya
Downloads: 0
Masters Thesis, Obstetrics and Gynecology, India, Volume 12 Issue 4, April 2023
Pages: 749 - 753A Study on Maternal Serum Glycosylated Fibronectin as a Predictor of Pre-Eclampsia in Antenatal Women between 20-36 Weeks of Gestational Age
Dr. Indira Priyadharshini, Dr. Jothi Sundaram
Downloads: 0
Dissertation Chapters, Obstetrics and Gynecology, India, Volume 12 Issue 5, May 2023
Pages: 112 - 115Prospective Observational Study of Magnesium Sulphate as Pritchard Regimen in Severe Pre-Eclampsia and Eclampsia
Dr. Madhukar Gajanan Borkar, Dr. Bhaskar Murthy